Mortality Trends in Patients Aged 25 and Older With Comorbid COPD and Diabetes Mellitus in the United States: A CDC WONDER Database Study From 2000 to 2023
Authors:
- Muhammad AhmedMAMuhammad Ahmed
- Saba FatimaSFSaba Fatima
- Shaheer Bin ShafiqSSShaheer Bin Shafiq
- Khubaib Tariq MansoorKMKhubaib Tariq Mansoor
- Muhammad Abdullah NaveedMNMuhammad Abdullah Naveed
- Ahila AliAAAhila Ali
- Harigopal SandhyavenuHSHarigopal Sandhyavenu
- Binish QureshiBQBinish Qureshi
- Sivaram NeppalaSNSivaram Neppala
Open Access
- 1 January 2026
- journal article
- Published by Wiley in Canadian Respiratory Journal
- Vol. 2026 (1) , 3655829
Abstract
Introduction: Diabetes mellitus (DM) and chronic obstructive pulmonary disease (COPD) are among the leading chronic diseases that significantly impact global morbidity and mortality. Growing evidence indicates a bidirectional interplay between metabolic and pulmonary dysfunction. This study aims to identify the demographic and regional trends of DM and COPD‐related mortality in the United States from 2000 to 2023. Methodology: DM‐ and COPD‐related deaths in the United States from 2000 to 2023 were obtained from the CDC WONDER database using ICD‐10 code E10‐14 for DM and J40‐44 as the underlying cause of death. Results are presented as age‐adjusted mortality rates (AAMR) per 100,000 population, with Joinpoint regression used for trend analysis and to calculate annual percentage change (APC). Results: A total of 796,757 DM‐ and COPD‐related deaths were recorded. From 2000 to 2008, the AAMR for DM and COPD increased from 11.19 to 14.32, remaining relatively stable until 2018. This was followed by a significant rise to 19.03 in 2021 (APC: 10.57), before declining to 16.28 in 2023 (APC: −9.08). Men demonstrated a higher AAMR (19.28) than women (12.02); however, both experienced decline post‐2021, with rates falling to 20.54 in men (APC: −9.08) and 13.02 in women (APC: −8.33). AAMR increased among all racial groups except Asians and Hispanics. From 2000 to 2021, American Indians had the highest AAMR (30.48). After 2021, AAMR declined across all groups. Rural areas reported higher AAMR (19.02), compared to urban areas (12.85). AAMR in rural areas increased markedly from 2018 to 2020 (13.67). State‐level comparisons revealed substantial variation in AAMR. Oklahoma had the highest rate at 28.79, followed by West Virginia (28.53), Kentucky (26.74), Vermont (23.95), and Mississippi (20.83). In contrast, Hawaii (6.69), Utah (7.33), and Massachusetts (7.99) reported the lowest rates, all below 10. Regionally, the Midwest had the highest average AAMR (16.30). Conclusion: COPD‐related diabetes mortality rose from 2000 to 2020, highest among men, Non‐Hispanic American Indians, and rural populations, and then declined post‐2021. Findings indicate increased vulnerability during acute events, highlighting the need for targeted interventions.Keywords
This publication has 45 references indexed in Scilit:
- CDC WONDER: Trends in diabetes mellitus mortality in the United States from 1968 to 2021Diabetes Research and Clinical Practice, 2025
- Trends in Mortality Due to Inflammatory Bowel Disease in the United States: A CDC WONDER Database Analysis (1999–2020)Digestive Diseases and Sciences, 2025
- Why do young men not seek help for affective mental health issues? A systematic review of perceived barriers and facilitators among adolescent boys and young menEuropean Child & Adolescent Psychiatry, 2024
- Sex differences in type 2 diabetesDiabetologia, 2023
- Urban–rural disparities in diabetes-related mortality in the USA 1999–2019Diabetologia, 2022
- Geographical variation in the prevalence of obesity, metabolic syndrome, and diabetes among US adultsNutrition & Diabetes, 2018
- Advanced glycation end products in the skin are enhanced in COPDMetabolism, 2014
- Cellular signalling of the receptor for advanced glycation end products (RAGE)Cellular Signalling, 2013
- The Effects of Socioeconomic Status on Health in Rural and Urban AmericaJAMA, 2002
- Glycemic Control and Cardiopulmonary Function in Patients With Insulin-Dependent Diabetes MellitusThe American Journal of Medicine, 1997